The Evolution of MASLD Management: From Revised Nomenclature to Disease-Modifying Therapies

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading cause of global chronic liver disease, with a prevalence of approximately 30%. This review outlines the diagnostic transition from the exclusionary non-alcoholic fatty liver disease (NAFLD) framework to the affirmative M...

Descripció completa

Dades bibliogràfiques

Autors principals:	Karolina Kornatowska, Szymon Kopciał, Mateusz Wiekiera, Adrianna Wiekiera, Paweł Budzik, Mateusz Tyniec, Kamal Morshed
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2026-05-01
Col·lecció:	Gastroenterology Insights
Matèries:	MASLD MASH CMRFs FIB-4 Index Resmetirom GLP-1RAs
Accés en línia:	https://www.mdpi.com/2036-7422/17/2/33
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!